The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday. Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in the US market. The company has received tentative approval from the US ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO ...

Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application (ANDA) from ...

A US district court in Delaware has filed a report saying that Indian generic drugmakers Lupin Labs and Zydus Cadila should be able to launch their generics prior to the conclusion of ongoing ...

Mylan has joined with India’s Lupin to market a biosimilar of Amgen/Pfizer’s inflammatory diseases blockbuster Enbrel (etanercept) in ex-US markets. Approved in a range of diseases including ...

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and ...

MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma ...